In a similar study, Thomas et al. (2021) aimed to determine whether the administration of lisinopril, an ACE-I, would have beneficial effects in a Drosophila model of AD that overexpresses human APP and human β-secretase in CNS tissue. The gene discussed is APP; the disease is Alzheimer disease.